Develops a crypto platform for buying, selling, and storing crypto assets. Offers a derivatives exchange for trading crypto futures and options. Now — the numbers.
The biggest line carries real weight, but it doesn’t decide everything on its own.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
This company is not turning a profit, so the market is pricing its sales instead: 3.7× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 5% of them.
Analysts' average target sits 19% above today's price.
Executives buying with their own money is usually read as confidence in the company’s future.
An investor who bought at the very peak is down 86% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 2 years, sales grew about 22% a year on average.
Sales run at $146.2M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 6 buys and 1 sell. Management buying with its own money is usually read as a good sign.
A loss of $582.8M against $146.2M in annual sales.
This stock swings about 2.7 times as much as the market average. Big rallies — and big drops — can both happen fast.
At the current pace of spending, the cash lasts about 1.2 years. After that, the company needs to find new money.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the growth trend.